Cervical Dysplasia Therapeutic Products and Pipeline Assessment Review H1 2015 Market Research Report Available at RnRMarketResearch.com
Dallas, TX (PRWEB) June 18, 2015 -- The report “Cervical Dysplasia - Pipeline Review, H1 2015” provides comprehensive information on the therapeutic development for Cervical Dysplasia. The report strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Complete report on Cervical Dysplasia with 21 market data tables and 11 figures, spread across 56 pages is available at http://www.rnrmarketresearch.com/cervical-dysplasia-pipeline-review-h1-2015-market-report.html .
Companies discussed in this Cervical Dysplasia - Pipeline Review, H1 2015 report include CEL-SCI Corporation, Helix BioPharma Corp., Inovio Pharmaceuticals, Inc., PDS Biotechnology Corporation, Vaccibody AS.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Drug Profiles mentioned in this report are CIGB-228, interferon alpha-2b (recombinant), Leukocyte Interleukin, PDS-0101, Vaccine for Cervical Intraepithelial Neoplasia, VB-1016, VGX-3100.
Order a purchase copy of this report at http://www.rnrmarketresearch.com/contacts/purchase?rname=392687 . (This is a premium report priced at US$2000 for a single user License.)
List of Tables
Number of Products under Development for Cervical Dysplasia, H1 2015 7
Number of Products under Development for Cervical Dysplasia - Comparative Analysis, H1 2015 8
Number of Products under Development by Companies, H1 2015 9
Number of Products under Investigation by Universities/Institutes, H1 2015 10
Comparative Analysis by Clinical Stage Development, H1 2015 11
Comparative Analysis by Early Stage Development, H1 2015 12
Products under Development by Companies, H1 2015 13
Products under Investigation by Universities/Institutes, H1 2015 14
Cervical Dysplasia - Pipeline by CEL-SCI Corporation, H1 2015 15
Cervical Dysplasia - Pipeline by Helix BioPharma Corp., H1 2015 16
Cervical Dysplasia - Pipeline by Inovio Pharmaceuticals, Inc., H1 2015 17
Cervical Dysplasia - Pipeline by PDS Biotechnology Corporation, H1 2015 18
Cervical Dysplasia - Pipeline by Vaccibody AS, H1 2015 19
Assessment by Monotherapy Products, H1 2015 20
Number of Products by Stage and Target, H1 2015 22
Number of Products by Stage and Mechanism of Action, H1 2015 23
Number of Products by Stage and Route of Administration, H1 2015 25
Number of Products by Stage and Molecule Type, H1 2015 27
Cervical Dysplasia Therapeutics - Recent Pipeline Updates, H1 2015 38
Cervical Dysplasia - Dormant Projects, H1 2015 53
Cervical Dysplasia - Discontinued Products, H1 2015 54
List of Figures
Number of Products under Development for Cervical Dysplasia, H1 2015 7
Number of Products under Development for Cervical Dysplasia - Comparative Analysis, H1 2015 8
Number of Products under Development by Companies, H1 2015 9
Comparative Analysis by Clinical Stage Development, H1 2015 11
Assessment by Monotherapy Products, H1 2015 20
Number of Products by Top 10 Targets, H1 2015 21
Number of Products by Stage and Top 10 Targets, H1 2015 22
Number of Products by Top 10 Routes of Administration, H1 2015 24
Number of Products by Stage and Top 10 Routes of Administration, H1 2015 25
Number of Products by Top 10 Molecule Types, H1 2015 26
Number of Products by Stage and Top 10 Molecule Types, H1 2015 27
Explore more reports on Diseases & treatment at http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/diseases-treatment .
More reports on Diseases & treatment:
Thymus Cancer - Pipeline Review, H1 2015
The report “Thymus Cancer - Pipeline Review, H1 2015” provides an overview of the Thymus Cancer's therapeutic pipeline. Companies discussed in this report includes Merck & Co., Inc., Novartis AG, Onxeo SA, Sumitomo Dainippon Pharma Co., Ltd. Complete report available at http://www.rnrmarketresearch.com/thymus-cancer-pipeline-review-h1-2015-market-report.html .
Salivary Gland Cancer - Pipeline Review, H1 2015
This report provides comprehensive information on the therapeutic development for Salivary Gland Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. Companies discussed in this report includes AstraZeneca PLC, Bayer AG, Incuron, LLC, Otsuka Holdings Co., Ltd., Plexxikon Inc. Complete report available at http://www.rnrmarketresearch.com/salivary-gland-cancer-pipeline-review-h1-2015-market-report.html .
Oropharyngeal Cancer - Pipeline Review, H1 2015
The report reviews key pipeline products under a drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities. Companies discussed in this report include Advaxis, Inc., AstraZeneca PLC, AVEO Pharmaceuticals, Inc., Merck & Co., Inc., Novartis AG, Serina Therapeutics, Inc., VLPbio. Complete report available at http://www.rnrmarketresearch.com/oropharyngeal-cancer-pipeline-review-h1-2015-market-report.html .
About Us:
RnRMarketResearch.com is an online database of market research reports that offers in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offers customized market research reports for multiple industries.
Ritesh Tiwari, RnR Market Research, http://www.rnrmarketresearch.com/, +1 (888) 391-5441, [email protected]
Share this article